PDS Biotechnology
PDSB
PDSB
55 hedge funds and large institutions have $166M invested in PDS Biotechnology in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.04% more ownership
Funds ownership: 2.47% → 2.51% (+0.04%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
55
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$5.68M | |
| 2 | +$2.81M | |
| 3 | +$1.97M | |
| 4 |
Renaissance Technologies
New York
|
+$1.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.2M |
Top Sellers
| 1 | -$7.02M | |
| 2 | -$2.7M | |
| 3 | -$1.33M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$601K |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$468K |